ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 34 filers reported holding ELEDON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,196 | -36.9% | 27,150 | -36.9% | 0.00% | – |
| Q2 2023 | $58,913 | +196276.7% | 43,002 | +241.2% | 0.00% | – |
| Q1 2023 | $30 | -99.9% | 12,605 | +5.5% | 0.00% | – |
| Q1 2022 | $47,000 | -70.6% | 11,951 | -67.0% | 0.00% | – |
| Q4 2021 | $160,000 | +146.2% | 36,242 | +243.6% | 0.00% | – |
| Q3 2021 | $65,000 | -54.2% | 10,549 | -41.4% | 0.00% | – |
| Q2 2021 | $142,000 | -9.0% | 17,993 | +23.3% | 0.00% | – |
| Q1 2021 | $156,000 | – | 14,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $8,280,000 | 0.60% |
| CM Management, LLC | 75,000 | $464,000 | 0.35% |
| BVF INC/IL | 1,363,435 | $8,426,000 | 0.33% |
| Cormorant Asset Management, LP | 1,305,095 | $8,065,000 | 0.33% |
| Ikarian Capital, LLC | 344,578 | $2,129,000 | 0.15% |
| Woodline Partners LP | 781,376 | $4,829,000 | 0.08% |
| Eversept Partners, LP | 114,008 | $704,569 | 0.05% |
| INGALLS & SNYDER LLC | 51,149 | $316,000 | 0.01% |
| Virtu Financial LLC | 18,610 | $115,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 34,630 | $214,000 | 0.01% |